contact us jpkrencn

お知らせ

業界動向

あなたはここにいる:ホーム > お知らせ > 業界動向 > Congratualtions

Congratualtions

著者:medicilon   アップロード:2020-06-04  閲読回数:

Congratualtions to Medicilon’s partner, Bio-Thera, on obtaining NMPA’s approval of clinical trials of BAT1308.

On May 27th, 2020, Bio-Thera Solutions, Ltd, annouced the approval of clinical trials on BAT 1308, an anti PD-1 monoclonal antibody. Medicilon participated in BAT 1308’s preclinical study by conducting the In Vivo PK test and safety evaluation tests under GLP.

上の:ノー上の

下に:Congratulations on the successful listing of Kintor Pharma